News

With the introduction of genAI tool Elsa at the FDA in June, the technology is playing a greater role in the medical device review process.
AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...
Investing.com -- PTC Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) for the ...
Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...
Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 11.2% in pre-market trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Mesoblast Limited stands tenth on our ...
Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...
Investing.com -- Entera Bio Ltd (NASDAQ: ENTX) stock jumped 9.1% in pre-market trading after the FDA agreed that the company’s New Drug Application (NDA) for EB613 could use bone mineral density (BMD) ...
Investing.com -- Stereotaxis (NYSE: STXS) stock surged 12% after the company received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its MAGiC Sweep catheter, the world’s first ...
Investing.com -- Celcuity Inc. (NASDAQ: CELC) stock surged over 100% following the announcement of positive Phase 3 trial results for its breast cancer drug gedatolisib, which showed unprecedented ...
The UK’s new industrial strategy signals a decisive shift toward state-backed innovation, investment, and regulatory reform.
EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...